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Abstract
Purpose: The accuracy of delivered dose is essential to the quality of radiotherapytreatment and tumor response. Generally, there are many types of dosimeter havebeen used to verify the dose from the treatment; however, most of thesedosimeters are impractical for clinical situation. The goal of this study was toassess an absolute dose derived from the Monte Carlo (MC) method for theso-called 6- and 10-MV photon beams obtained from Varian Clinac 2100C linearaccelerator. Methods: The deposited doses have been calculated by the EGSnrccode system and, then, were converted into the absolute doses. We were alsomeasured, in water phantom, by an ionization chamber and, in the chest region ofRando phantom, by a thermoluminescense dosimeter (TLD). Results: Thesimulated data in water phantom agree with the results from both themeasurement and previous studies within 2%. By comparing the absolute dose atvarious positions within the Rando phantom from two-opposing irradiated fields,the difference from MC calculation and TLD measurement was within 2%.Unfortunately, the calculated doses obtained from the collapse cone convolution(CCC) algorithm showed notable difference from that of the MC method. For theinterface region within the provided field, it was higher than that from the MCmethod by almost 5% for the 6-MV and 7% for the 10-MV photon beam.
Conclusion: Our findings indicated that the MC method was on the level with themeasurement for the dose determination, especially within the delivered field to aheterogeneous phantom.
Keywords: Monte Carlo method, Absolute dose, TLD measurement, Randophantom
1. IntroductionMonte Carlo (MC) methods have many fields ofapplication in radiation therapy and are recognized asthe alternative tool for simulating beam passing throughheterogeneities region particularly for lung and bonyanatomy, and tissue interfaces. However, the clinicalimplementation of these techniques has been limited bylong calculation times. Consequently, MC simulationshave only been used as an important quality assurance(QA) tool for relative comparison with measurement orcalculation using dosimeters and commercial treatmentplanning system (TPSs), respectively.
Because of the limitation of measurements in realpatient-specific, MC method offers an alternativedetermination of dose delivered to the entire treatmentvolume in real patient geometry and heterogeneities.Although TPS can give dose distribution conveniently,the significant differences between MC and TPScalculation in such complex situations are still found1-4.For example, Han et al.1 previously compared variousdose calculation algorithms for homogeneous water andmultilayer slab virtual phantoms. The study reportedlarge dose deviation for the collapse cone convolution(CCC) algorithm in the bone, lung, and interface regions
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in which the spatial distributions of these differencesdepend on the field sizes and energies.Since the clinical treatment plan is commonly presentedin term of absolute dose on patient computedtomography (CT) data sets, the accuracy of absolutedosimetry in MC simulation should be concerned.Several reports propose the algorithm for absolutedosimetry based on MC data4-8, however no benchmarkinformation is provided regarding the accuracy of theMC-calculated absorbed doses. The calculation from thestudies of Francescon et al.5, and Leal et al.7 did notinclude the backscatter into the monitor chamber. Incontrast, Popescu et al.4 have provided the absolute doseformula accumulated the backscatter from the jawsentering the monitor chambers. The MC-calculated doseand the experimentally absorbed dose were comparedto verify the MC calculation. According to theirinvestigation, the MC absolute dose calculationsnormalized by the incident particle are in excellentagreement with experiment with the percentagedifferences of less than 2%.The purpose of this study was to investigate the absolutedose calculation performance of MC method on theCT-datasets for both 6- and 10-MV therapeutic photonbeams obtained from a Varian Clinac 2100 C linearaccelerator. The simulated results derived in the waterphantom and the Rando phantom were analyzed andcompared against the CCC dose calculation, ionizationchamber and TLDs measurements.
2. Methods and Materials
2.1. MeasurementsVarian Clinac 2100C (Varian, Palo Alto, USA) linearaccelerator was used in this study. The measurementswere performed at the presumed 6- and 10-MV photonbeam. In this study, the percentage depth doses (PDDs)and the beam profiles for the 2020 cm2 field size wereobtained to investigate the performance of our MCsimulation. The PDD curves and the beam profiles wereacquired using the RFA-300 dosimetry system(Wellhofer Scanditronix GmbH, Germany) at the depthranging from 0 to 30 cm. The dose scanning step was 2mm using a silicon p-type photon semiconductor(Wellhofer Scanditronix, Germany) dosimeter.To ensure the reliability of our simulation for the otherfield sizes, we also obtained the actual measured dose ina water phantom (Wellhofer Scanditronix, Germany)using a Farmer ionization chamber type FC65-G(Wellhofer Scanditronix, Germany) and a parallel-plateionization chamber type 34001 (PTW-Freiburg)connected to the DOSE-1 Electrometer (iba dosimetry).Commonly a Farmer chamber and a parallel-platechamber is the standard dosimeter for clinical use toacquire the machine output and the absolute dose atshallow depth, respectively. Measurements wereperformed by a Farmer chamber along the central axis
of the radiation beam for five square field sizes of 5, 10,15, 20 and 30 cm2 with a constant source-axis distance(SAD) of 100 cm at the depth of 5, 10 and 20 cm. While aparallel-plate chamber was used to acquire themeasured data in the same situation at the maximumdepth to avoid the effect of electron contamination.9Each measured signal was taken from an average of fivereadings for an output variation. The absorbed dose wasdetermined and calculated followed the IAEA TRS-398dosimetry protocol.9Other measurements were performed usingthermoluminescense dosimeters (HARSHAW ChemicalCo, Solon, OH) in the chest region of Alderson radiationtherapy phantom (Model 457; Radiology SupportDevices, USA) to investigate the heterogeneity effect.Lithium fluoride (LiF) crystals doped with magnesiumand titanium in the form of TLD rods (HARSHAWChemical Co, Solon, OH) was used for measuring. TLDrods have been inserted in the Rando phantom andirradiated with two-opposing fields for the mediastinaltreatment. Because there was no significant difference ofbeam quality for LiF-TLD10, the correction factors foreach individual TLD were provided by an irradiationwith a known dose from a Cobalt-60 machine(THERATONIC 780C) at the depth of maximum dose. Toensure the reading consistency, these reading from eachmeasured position in three repeated times wereacquired by TL reader (Model 5500; HARSHAWChemical Company, Salon, OH).
2.2. Monte Carlo simulationEGSnrc Monte Carlo code system, provided by theNational Research Council of Canada11-12 was used tosimulate photon beam from the medical linearaccelerator. It composes of the two sub-codes; BEAMnrcand DOSXYZnrc. The BEAMnrc code was used to modelthe linac’s head as a series of component modules. Inorder to eliminate the forward dose from backscatterdose for every simulated field, the simulation of ourlinac head was separated. The first phase space, A, wasscored above the jaws resulting in the dose accumulatedin the monitor chamber due to the beam entering thechamber from above. Another phase space, B, wasscored under the jaws resulting in the dose accumulatedin the monitor chamber due to the particlesbackscattered from the jaws. DOSXYZnrc allows theradiation transport and dose deposition in the virtualphantoms or in CT data to be calculated in Cartesiancoordinates. Generally, the MC dose reports thedose-to-medium in medium (D(m,m)).Before estimating the MC absolute doses, the initialenergy and the radius distribution of the incidentelectron beam interacted on the target were adjustedaccording to the match between the simulated andmeasured results of the percentage depth doses and thedose profiles at a 10 cm depth for a 2020 cm2 field. Forthe depth doses, the matching condition for both 6- and
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10-MV therapeutic photon beams started from the depthat a maximum dose to 25 cm. For the 6-MV photon beam,from the best match, the obtained initial energy andradius of electron beam were 6.2 MeV and 1.0 mm,respectively. The optimal incident electron energy andbeam radius for the 10-MV photon beam were 10.4 MeVand 1.3 mm, respectively. These simulated parametersgave the best similar characteristics to that of therealistic photon beams.The EGSnrc settings used in the calculation werefollowing: the global electron transport cut-off energy(ECUT) = 700 keV, the global photon transport cut-offenergy (PCUT) = 10 keV. Cross section data weregenerated using PEGS4. The description of otherparameters could be found in BEAMnrc and DOSXYZnrcmanual.13-15 For calculating the PDD, the beam profile,and the machine output in the DOSXYZnrc code, thesimulated beam interacted on a water phantom with thevoxel sizes of 0.50.50.5 cm3. The simulated dose is amean value in each calculation voxel per incidentparticle of the radiation source; therefore it isproportional to the dose per monitor unit.The results obtained in the water phantom were used toverify the accuracy of MC-based data, and to calculateabsolute dose values in the CT phantom. For dosecalculation in the CT-based phantom, the voxel sizeswere set to 0.40.40.5 cm3 to match that on the dosegrid resolution of TPS. The simulated results wereconverted to the absolute dose according to the methodproposed by Popsecu et al.4. The absolute dose at thepoint (x, y, z) in the phantom is given by equations (1)and (2):






















where Dxyz is the dose per incident history along thebeam central axis deposited in a prescribed voxel, Dch isthe dose per incident history accumulated in themonitor chamber, Dchforward is the  dose contributionfrom the beam interaction with monitor chamber,
back
chD is the dose contribution from the beaminteraction with collimator, calxyzD is the normalizeddose at the calibration point of a clinical accelerator,
cal
absxyzD , is the absolute dose at the calibrated point (x, y,z) in the phantom, MUabschD1 , is the absolute dose at themonitor chamber corresponding to one monitor unit, U
is the number of monitor units, Ne is the number ofincident electrons. Table 1 summarized the followingvalues determined from both 6- and 10-MV photonbeams.
2.3. Clinical geometryCT image datasets were acquired for a Rando phantomthrough a MX IDT8000 (Philips Healthcare, Andover,MA) CT machine with a slice thickness of 3 mm. DuringCT scanning, all holes are plugged with bone-, softtissue-, and lung-equivalent pins. The images wereacquired and imported into TPSs and DOSXYZnrc usingthe CTCREATE program15 which converts the CT datainto the desired dimensions, material types, and massdensities based on a CT number to density correlation.A clinical two-field opposing conventional plan withgantry angles 0 (anterior), 180 (posterior), 150(left-posterior), and 330 (right-anterior) for bothphoton beam energies was delivered to a Randophantom. The investigated beams were the 10×12 cm2field for the AP-PA direction, and the 8×15 cm2 field forRAO-LPO direction. Each of the fields was placed ontoeach site of phantom to generate 100 cGy to itsisocenter.
2.3. Collapse cone convolution algorithmThe Collapse cone convolution (CCC) algorithm16 inPinnacle 7.6C TPSs (Philips Medical Systems, Inc.,Fitchburg, WI) uses convolution/superposition methodsto compute TERMA convolved with energy depositionkernels and to account for the effects of tissueheterogeneities. All plans calculated with DOSXYZnrcwere recalculated using the CCC algorithm. The same CTnumber-density conversion was used for the CCCcalculations. The CCC TPS also reports thedose-to-medium in medium (D(m,m)) as default inPinnacle.
3. Results
3.1. Absolute dose calculation using the MC dataTo verify the accuracy of simulated results for the 6- and10-MV photon beam from Varian machine usingBEAMnrc/DOSXYZnrc code, the dose at the depth ofmaximum dose, 5, 20 cm and at the depth of 10 cmwhich is the practical reference depth for calibrationwere compared with the measured results. Thedifference between the absolute dose at different depthsfor the square open field side of 5, 10, 15, 20, and 30 cm2for 6- and 10-MV photon beam in water phantom werepresented in Figures 1 and 2, respectively. The solidpoints represented the measured dose, while the lightpoints were the simulated dose. From the results, mostof our simulated data were similar to measured datawith percent differences of less than 2%.
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Figure 1: The absolute dose at different depths on the central axis for the square field side of 5, 10, 15, 20, and 30 cm2 for6-MV photon beam.
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Table 1: The numerical values specific to our study for absolute dose calculation.Parameters Numerical values6 MV 10 MV(Gy/incident particle) 2.261×10-150.2% 5.473×10-150.1%(Gy/incident particle) 6.241×10-17 1.0% 1.748×10-16 0.8%(Gy/incident particle) 1.066×10-16 0.9% 2.611×10-16 0.7%(cGy/MU) 0.787 0.839
Table 2:Monte Carlo and measured relative output factors (ROF) for both 6- and 10-MV photon beams.Fieldsize(cm2) 6 MV 10 MVMC_ROF MEAS_ROF %Diff MC_ROF MEAS_ROF %Diff5×5 0.9123 0.8981 1.59 0.9202 0.9139 0.7010×10 1.0000 1.0000 0.00 1.0000 1.0000 0.0015×15 1.0559 1.0573 0.13 1.0464 1.0478 0.1420×20 1.0940 1.0943 0.02 1.0714 1.0754 0.3730×30 1.1499 1.1452 0.41 1.1048 1.1160 1.01
Table 3: Comparison of the relative output factor (ROF) for the 6-MV photon beams obtained from our MC simulation andfrom previous study4.Field size(cm2) MCsimulation4 Our MCsimulation Percentagedifference (%)5×5 0.9020 0.9123 1.1410×10 1.0000 1.0000 0.0015×15 1.0610 1.0559 0.4820×20 1.1050 1.0940 1.0030×30 1.1590 1.1499 0.79
Table 4: Comparison the MC and TLD absolute doses for a clinical simple plan delivered on the CT-based data of the Randophantom in the 6- and 10-MV photon beam.
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Table 5: Comparison the MC and CCC absolute doses for a clinical simple plan delivered on the CT-based data of the Randophantom in the 6- and 10-MV photon beam.No Regions 6 MV 10 MVMC dose(cGy) CCC dose(cGy) Percentagedifference (%) MC dose(cGy) CCC dose(cGy) Percentagedifference (%)AP-PA technique1 Lung (iso) 195.0 200.4 -2.8 191.7 200.1 -4.42 Lung 197.3 203.3 -3.0 194.5 203.2 -4.53 Lung 195.3 201.2 -3.0 190.7 199.6 -4.74 Tissue 203.9 212.0 -4.0 198.0 205.8 -3.95 Interface* 199.4 207.6 -4.1 192.7 205.0 -6.46 Interface* 189.7 194.5 -2.5 186.2 196.0 -5.37 Interface* 207.3 214.1 -3.3 197.1 209.4 -6.2RAO-LPO technique1 Lung (iso) 192.2 200.0 -4.1 188.9 199.9 -5.82 Lung 195.0 202.4 -3.8 190.2 201.4 -5.93 Lung 184.8 191.7 -3.7 181.1 191.5 -5.74 Tissue 217.0 221.6 -2.1 209.0 214.8 -2.85 Interface* 195.8 205.1 -4.8 191.8 203.2 -5.96 Interface* 197.7 204.8 -3.6 191.9 202.8 -5.77 Interface* 187.9 195.0 -3.8 183.8 194.4 -5.8*Interface between lung and tissue densitiesThe absolute dose at the relevant depths in a waterphantom can be computed using the percentage depthdose, dose profiles and relative output factors (ROF)accounting for the effect of field sizes. Commonly, theROF is defined at a point (x, y, z) along the beam centralaxis in a water phantom. It is the ratio of the dose underthe given field and the corresponding dose under a1010 cm2 field for the same number of MU. In thisstudy, the relative output factor measurements weretaken in a water phantom at a depth of 10 cm for both6-and 10-MV photon beams. The MC simulations werecarried out with a statistical uncertainty of less than 1%in the voxel placed at the isocenter. The relative outputfactor test gave the result shown in Table 2.We found that our MC calculation accurately producesmeasured relative output factors (ROF). These resultsare consistent with the measured data and the data fromother investigators.4,17,18 As shown in Table 3, our MCsimulated ROFs for 6 MV photon beam energy agreewith those of Popescu et al.4, since they had performedreliable measurement at the same beam energy fromsimilar medical linear accelerators (the Varian Clinac21EX). Therefore, we conclude that our calculated ROFsusing the MC simulation can be used for finding theabsolute dose in the square fields with the side rangingfrom 5 to 30 cm.
3.2. Absolute dose comparison in CT-based dataThe clinical conventional plans were calculated andmeasured in the chest region of the Rando phantom. Toreduce the discrepancies of calculation in the CT-baseddata, the field size larger than 55 cm2 were selected forboth of 6- and 10-MV photon beams. The validation ofthe absorbed dose derived from the MC calculation inCT-based data was performed for a 10×12 cm2 field forthe AP-PA direction and an 8×15 cm2 field for RAO-LPO
direction. Table 4 compares the MC absolute dosecalculated by equation (1) with the measured dosedetermined by a set of calibrated TLD placed inside thetreatment field. The agreement of MC with TLD wasevaluated using the point dose analysis. Our resultsshowed that the MC absolute dose in the conventionaltreatment technique have acceptable agreement withthe TLD in lung and interface region. The maximumdifference was less than 2% for both of 6- and 10-MVphoton beam.In this work, the MC results were also compared to CCCdoses in the same treatment plan. Table 5 lists thepercent differences for the absolute doses comparisonbetween the MC and the CCC data in the chest region of aRando phantom for 6- and 10-MV photon beam energies.For 6-MV photon beam, the maximum difference for alltreatment plans was 4.75%. This difference was 6.38%in the case of the 10-MV photon beam.
4. DiscussionAs shown in the study of Lie et al.6, the output of clinicalaccelerator is affected by the backscatter from jawstowards the monitor chamber. They found that thebackscatter decreases approximately linearly withincreasing field size. Therefore, an essential componentof absolute dosimetry based on the MC simulation is thedose accumulated in the monitor chamber, which is usedto control the radiation output for precise delivery ofprescribed dose. Normally, the monitor chambers arecalibrated in such a way that one monitor unit (1 MU)corresponds to 0.01 Gy at the depth of the maximumdose on the central axis in a water phantom underreference dosimetry conditions. Additionally, thecorrelation between the dose accumulated in themonitor chamber and the number of incident electron
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on the linac target is also important. Therefore, in thisstudy the forward and backscattered doses have beenseparated in the simulation in order to evaluate theaccuracy of the derived absolute doses. As shown inFigures 1 and 2, the absolute dose for both simulatedand measured data increased linearly with increasingfield sizes, likely due to increasing amounts of electronsscattering from the collimator, air, and phantom. Thehigher difference can be found in the square field of 55cm2 at the depth of maximum dose because ourmatching condition between the simulated andmeasured data has been only performed for the 20x20cm2 field size. The calculated output for the 55 cm2 fieldwas overestimated in this depth. For the 6-MV photonbeam, the measured dose at the field size of 55 cm2obtained from this dosimeter was 4% higher than thatsimulated dose. The discrepancy was reduced to 1.3%for the 10-MV photon beam. It was seen that this effect ismore pronounced in low energy photon beam, becausethe effect of electron contamination in the shallow depthof maximum dose for the 6-MV, 1.5 cm depth, is higherthan that for the 10-MV photon beam, 2.5 cm depth.Comparing with the MC calculations, the CCC dosesshow a large overestimation in all studied points. Wefound that the discrepancies were distributed dependingon the positions and energies. As seen in Table 5, thelargest differences between the MC and the CCC dataoccur in the interface region for both of our photonbeam energies. The overestimations for 10 MV werehigher than 6 MV both in the lung and interface region.These results are similar to those found by otherresearchers.1,19-21 While the MC doses near the interfaceregion were comparable to those from TLDmeasurement, the CCC doses have notable differences,which is consistent with the reports of Han et al.1Because the presence of large heterogeneities is notaccurately accounted for by thesuperposition-convolution algorithm, the dosecalculation uncertainties of CCC mostly occur near theinterface of materials with large density differences. Thelimitation of the CCC dose calculation in this region isdue to its inability to model the backscattered photonsand backscattered secondary electrons originating fromboth upstream and downstream tissues across theinterface. In this study, we are aware of our CCCcalculation limitations using the identical grid size tothat of MC simulation. This may be considered too big inpractical treatment planning.
5. ConclusionFor the depth beyond the depth of maximum dose, theMC-absolute dose for these 6- and 10-MV photon beamswere in good agreement with the measurements fromsimilar machines. Our calculated ROFs using the MCsimulation were justified and can be used for finding theabsolute dose in the square field with its side rangesfrom 5 to 30 cm. The absolute doses based on the MC
data in conventional treatment technique haveacceptable agreement with the TLD in lung and interfaceregion of CT Rando phantom set. The maximumdifference was less than 2% for both of 6- and 10-MVphoton beam. In contrary, the large variability was alsoobserved at the interface region between theMC-absolute doses and the CCC dose calculations.
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